How do I buy Estrella Immunopharma (ESLA) stock?

You can purchase shares of Estrella Immunopharma (NASDAQ:ESLA) through any online brokerage.View our list of the best stock brokerages

Who are Estrella Immunopharma (ESLA) competitors?

Other companies in Estrella Immunopharma’s space includes: Kezar Life Sciences Inc (NASDAQ:KZR), Evaxion AS (NASDAQ:EVAX), OS Therapies Inc (AMEX:OSTX), MAIA Biotechnology Inc (AMEX:MAIA) and ABVC BioPharma Inc (NASDAQ:ABVC).

What is the forecast, or price target, for Estrella Immunopharma (ESLA) stock?

Estrella Immunopharma has a consensus price target of $16.00.

What is the current price for Estrella Immunopharma (ESLA)?

The stock price for Estrella Immunopharma (NASDAQ: ESLA) is $1.1971 last updated January 9, 2026 at 5:07 PM EST.

Does Estrella Immunopharma (ESLA) pay a dividend?

There are no upcoming dividends for Estrella Immunopharma.

When is Estrella Immunopharma (NASDAQ:ESLA) reporting earnings?

Estrella Immunopharma does not have any upcoming earnings scheduled.

Is Estrella Immunopharma (ESLA) going to split?

There is no upcoming split for Estrella Immunopharma.

What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Estrella Immunopharma (ESLA) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission ...

Comments